EGFR and Anorexia: The most common adverse events were rash (40.0% in the EGFR-TKI plus thymosin group and 38.5% in the EGFR-TKI group), diarrhea (23.1% vs 25.4%), dry skin (20.0% vs 20.8%) and anorexia (9.2% vs 10.0%).